Abbott

Five advancements in diabetes treatment to watch
Five advancements in diabetes treatment to watchThe healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.
Integrating computer-assisted toric IOL implantation
Integrating computer-assisted toric IOL implantationSince making the switch to a markerless toric alignment system, Bryan S. Lee, MD, JD, explains how the technology has eliminated ink marking from his surgical regimen.
Multifocals show similar results but lower power offers better vision rangeBoth the Tecnis multifocal +2.75 D and +4.00 D IOLs had good visual results, but the +2.75 D IOL had a better range of vision across near, intermediate, and distance.
How has ophthalmology changed in 2016?
How has ophthalmology changed in 2016?As the end of the year approaches, we wanted to take a look back at the predictions our Editorial Advisory Board members made for 2016 and see how far we’ve come in the last 12 months.
Johnson & Johnson to acquire Abbott Medical Optics
Johnson & Johnson to acquire Abbott Medical OpticsReady for some big news? Johnson & Johnson announced they have entered into a definitive agreement to acquire Abbott Medical Optics (AMO) for $4.325 billion in cash. AMO’s business segments include cataract surgery, laser refractive surgery, and consumer eye health, and reported sales in 2015 were $1.1 billion.
FDA approves one-of-a-kind IOL with extended range of vision
FDA approves one-of-a-kind IOL with extended range of visionIt has been a history-making week for the ophthalmic world, and the FDA approval of the first IOL with extended range of vision (Tecnis Symfony IOL, Abbott) has only added one more reason for celebration.
New-generation presbyopia-correcting IOLThe U.S. IDE clinical trial of the investigational extended range of vision IOL (Model ZXR00; Tecnis Symfony Extended Range of Vision IOL, Abbott Medical Optics) found that the implant delivered a full range of uncorrected vision and minimized or eliminated the need for spectacle wear in most patients.
How will ophthalmology evolve in 2016?
How will ophthalmology evolve in 2016?Ophthalmology Times spoke with its Editorial Advisory Board members to get their thoughts on how the field of ophthalmology is growing, what advances they are highly anticipating, and what major hurdles ophthalmologists will face in 2016. A special thanks to Peter J. McDonnell, MD, Randall Olson, MD, Andrew G. Lee, MD, Sharon Fekrat, MD, and Robert K. Maloney, MD, for giving us a sneak peak at what the new year will bring.
Irritable bowel syndrome therapeutics market dynamics
Irritable bowel syndrome therapeutics market dynamicsCurrently, the IBS treatment market is naïve and underpenetrated, with only 4 products indicated for IBS in the 7MM.
Abbott receives 510(k) clearance, makes deal with ZeissAbbott recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for two new products used in laser cataract surgery, the Cataract Operating System 3 (cOS3) and the Liquid Optics Interface 12, both for the company’s Catalys Precision Laser System.